$IZM
ICZOOM Group Inc. Stock $izm

$izm Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 20-F Financial Statement

#000121390023081728 Filed on October 31, 2023

Income Statement

Concept	2023 Q2	2023
Revenue	$94.20M	$214.4M
YoY Change	-67.56%	-26.16%
Cost Of Revenue	$92.00M	$209.1M
YoY Change	-67.44%	-25.99%
Gross Profit	$2.200M	$5.293M
YoY Change	-71.85%	-32.27%
Gross Profit Margin	2.34%	2.47%
Selling, General & Admin	$2.100M	$4.418M
YoY Change	-43.81%	18.2%
% of Gross Profit	95.45%	83.47%
Research & Development		$400.0K
YoY Change		-24.55%
% of Gross Profit		7.56%
Depreciation & Amortization	$110.0K	$197.2K
YoY Change	84.87%	33.2%
% of Gross Profit	5.0%	3.73%
Operating Expenses	$2.100M	$4.418M
YoY Change	-52.74%	-0.58%
Operating Profit	$100.0K	$875.0K
YoY Change	-97.03%	-74.04%
Interest Expense	$1.000M	$1.200M
YoY Change	-4146.94%	-4956.33%
% of Operating Profit	1000.0%	137.14%
Other Income/Expense, Net	$0.00	$1.142M
YoY Change	-100.0%	7126.63%
Pretax Income	$1.100M	$2.017M
YoY Change	-65.16%	-36.12%
Income Tax	$300.0K	$265.7K
% Of Pretax Income	27.27%	13.17%
Net Earnings	$800.0K	$1.751M
YoY Change	-68.87%	-31.86%
Net Earnings / Revenue	0.85%	0.82%
Basic Earnings Per Share		$0.19
Diluted Earnings Per Share	$0.08	$0.18
COMMON SHARES
Basic Shares Outstanding		9.201M shares
Diluted Shares Outstanding		9.919M shares

Balance Sheet

Concept	2023 Q3	2023 Q2	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments		$1.110M	$1.110M
YoY Change		-2.28%	-2.28%
Cash & Equivalents		$6.413M
Short-Term Investments		$0.00	$0.00
Other Short-Term Assets		$6.960M	$6.960M
YoY Change		-23.99%	-23.99%
Inventory		$833.9K	$830.0K
Prepaid Expenses		$54.28K
Receivables		$76.69M	$76.69M
Other Receivables		$1.287M	$1.290M
Total Short-Term Assets		$86.89M	$86.89M
YoY Change		-1.71%	-1.71%
LONG-TERM ASSETS
Property, Plant & Equipment		$126.0K	$990.0K
YoY Change		-84.48%	21.95%
Goodwill
YoY Change
Intangibles		$288.4K
YoY Change		-23.76%
Long-Term Investments
YoY Change
Other Assets		$10.60K	$10.00K
YoY Change		-72.99%	-74.52%
Total Long-Term Assets		$1.288M	$1.290M
YoY Change		4.79%	4.93%
TOTAL ASSETS
Total Short-Term Assets		$86.89M	$86.89M
Total Long-Term Assets		$1.288M	$1.290M
Total Assets		$88.18M	$88.18M
YoY Change		-1.63%	-1.62%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$51.13M	$51.13M
YoY Change		-14.16%	-14.15%
Accrued Expenses		$1.560M	$1.560M
YoY Change		97.1%	97.1%
Deferred Revenue		$1.671M
YoY Change		-54.23%
Short-Term Debt	$2.00	$14.02M	$15.53M
YoY Change		14.84%	27.19%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$72.26M	$72.26M
YoY Change		-8.14%	-8.13%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$0.00
YoY Change
Other Long-Term Liabilities		$380.0K	$380.0K
YoY Change		-20.91%	-20.91%
Total Long-Term Liabilities		$375.1K	$380.0K
YoY Change		-21.93%	-20.91%
TOTAL LIABILITIES
Total Short-Term Liabilities		$72.26M	$72.26M
Total Long-Term Liabilities		$375.1K	$380.0K
Total Liabilities		$72.63M	$72.63M
YoY Change		-8.22%	-8.22%
SHAREHOLDERS EQUITY
Retained Earnings		-$5.334M
YoY Change		-24.71%
Common Stock		$0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$15.54M	$15.54M
YoY Change
Total Liabilities & Shareholders Equity		$88.18M	$88.18M
YoY Change		-1.63%	-1.62%

Cashflow Statement

Concept	2023 Q2	2023
OPERATING ACTIVITIES
Net Income	$800.0K	$1.751M
YoY Change	-68.87%	-31.86%
Depreciation, Depletion And Amortization	$110.0K	$197.2K
YoY Change	84.87%	33.2%
Cash From Operating Activities	-$1.840M	-$3.752M
YoY Change	-1603.27%	-2807.93%
INVESTING ACTIVITIES
Capital Expenditures	$50.00K	$81.91K
YoY Change	146.55%	156.86%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$50.00K	-$144.2K
YoY Change	-6.92%	-116.7%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$4.434M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	6.730M	$8.749M
YoY Change	360.41%	-350.27%
NET CHANGE
Cash From Operating Activities	-1.840M	-$3.752M
Cash From Investing Activities	-50.00K	-$144.2K
Cash From Financing Activities	6.730M	$8.749M
Net Change In Cash	4.840M	$3.461M
YoY Change	216.25%	-238.81%
FREE CASH FLOW
Cash From Operating Activities	-$1.840M	-$3.752M
Capital Expenditures	$50.00K	$81.91K
Free Cash Flow	-$1.890M	-$3.834M
YoY Change	-1950.76%	-3694.36%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-06-30
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41645
CY2023	dei	Entity Registrant Name EntityRegistrantName	ICZOOM GROUP INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	Room 3801, Building A, Sunhope e·METRO, No. 7018 Cai Tian Road
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Futian District
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Shenzhen
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	518000
CY2023	dei	Security12b Title Security12bTitle	Class A Ordinary shares, par value $0.16 per share
CY2023	dei	Trading Symbol TradingSymbol	IZM
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	3487
CY2023	dei	Auditor Name AuditorName	Alliance LLP
CY2023	dei	Auditor Location AuditorLocation	Singapore
CY2023Q2	us-gaap	Cash Cash	1109834	usd
CY2022Q2	us-gaap	Cash Cash	1134416	usd
CY2023Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	5303533	usd
CY2022Q2	us-gaap	Restricted Cash Current RestrictedCashCurrent	1817607	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	1490	usd
CY2022Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	18000	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	76690246	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	76020296	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	833858	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	365615	usd
CY2023Q2	us-gaap	Supplies Supplies	1608941	usd
CY2022Q2	us-gaap	Supplies Supplies	6613280	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1341201	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2432913	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	86887613	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	88403617	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	126032	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	119244	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	862852	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	692571	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	288436	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	378338	usd
CY2023Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	10600	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14491	usd
CY2023Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	305	usd
CY2022Q2	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	24751	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1288225	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	1229395	usd
CY2023Q2	us-gaap	Assets Assets	88175838	usd
CY2022Q2	us-gaap	Assets Assets	89633012	usd
CY2023Q2	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	14022523	usd
CY2022Q2	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	11760387	usd
CY2022Q2	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable	100000	usd
CY2023Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	51127328	usd
CY2022Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	59558743	usd
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1671353	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3651700	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1508766	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	349684	usd
CY2023Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	2932137	usd
CY2022Q2	us-gaap	Taxes Payable Current TaxesPayableCurrent	2675002	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	524698	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	232221	usd
CY2023Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	469781	usd
CY2022Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	329924	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	72256586	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	78657661	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	375056	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	480436	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	375056	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	480436	usd
CY2023Q2	us-gaap	Liabilities Liabilities	72631642	usd
CY2022Q2	us-gaap	Liabilities Liabilities	79138097	usd
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	35000000	shares
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	35000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8826374	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8826374	shares
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	18795548	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14499213	usd
CY2023Q2	us-gaap	Other Additional Capital OtherAdditionalCapital	624097	usd
CY2022Q2	us-gaap	Other Additional Capital OtherAdditionalCapital	624097	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5334300	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-7085470	usd
CY2023Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-193368	usd
CY2022Q2	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1044856	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15544196	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	10494915	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	88175838	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	89633012	usd
CY2023	us-gaap	Sales Type Lease Interest Income SalesTypeLeaseInterestIncome	211123155	usd
CY2022	us-gaap	Sales Type Lease Interest Income SalesTypeLeaseInterestIncome	286539736	usd
CY2023	us-gaap	Direct Financing Lease Revenue DirectFinancingLeaseRevenue	3282071	usd
CY2022	us-gaap	Direct Financing Lease Revenue DirectFinancingLeaseRevenue	3836635	usd
CY2023	us-gaap	Revenues Revenues	214405226	usd
CY2022	us-gaap	Revenues Revenues	290376371	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	209112615	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	282561907	usd
CY2023	us-gaap	Gross Profit GrossProfit	5292611	usd
CY2022	us-gaap	Gross Profit GrossProfit	7814464	usd
CY2023	us-gaap	Selling Expense SellingExpense	1991992	usd
CY2022	us-gaap	Selling Expense SellingExpense	1931785	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2425587	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2511424	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	4417579	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	4443209	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	875032	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	3371255	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	1788870	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	301133	usd
CY2023	us-gaap	Investment Income Net InvestmentIncomeNet	-567915	usd
CY2022	us-gaap	Investment Income Net InvestmentIncomeNet	-356624	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	14748	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	30775	usd
CY2023	us-gaap	Gain Or Loss On Sale Of Previously Unissued Stock By Subsidiary GainOrLossOnSaleOfPreviouslyUnissuedStockBySubsidiary	125125	usd
CY2022	us-gaap	Gain Or Loss On Sale Of Previously Unissued Stock By Subsidiary GainOrLossOnSaleOfPreviouslyUnissuedStockBySubsidiary	213741	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-205249	usd
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-219020	usd
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-197945	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1141808	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-214169	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2016840	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3157086	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	265670	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	587276	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1751170	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2569810	usd
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	1238224	usd
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-817991	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	512946	usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	3387801	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9918931	shares
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	7413293	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	54171	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2569810	usd
CY2022	iczoom	Stock Issued During Period Value Effect Of Termination Of The Vie StockIssuedDuringPeriodValueEffectOfTerminationOfTheVIE	-360350	usd
CY2022	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	817991	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	10494915	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	102783	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1751170	usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	4433552	usd
CY2023	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-1238224	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	15544196	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	1751170	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	2569810	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	197233	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	148071	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-882	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	2296	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	381795	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	41968	usd
CY2023	iczoom	Reversal Provision For Doubtful Accounts ReversalProvisionForDoubtfulAccounts	-99003	usd
CY2022	iczoom	Reversal Provision For Doubtful Accounts ReversalProvisionForDoubtfulAccounts	30187	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	1851	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	1325616	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	54171	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	102783	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	197366	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	23465	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5994	usd
CY2023	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	383469	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	172794	usd
CY2022	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination	-205249	usd
CY2023	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables	-18000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3711373	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9211978	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	495580	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2096212	usd
CY2023	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	-5004076	usd
CY2022	us-gaap	Increase Decrease In Prepaid Supplies IncreaseDecreaseInPrepaidSupplies	-30759	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-315056	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-622011	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-6364245	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	5179267	usd
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1832960	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1632254	usd
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	421057	usd
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	454963	usd
CY2023	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-392422	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-22985	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-15764	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-455171	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3751832	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	138550	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	81913	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22218	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3096	usd
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	63698	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	9669	usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	4125704	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	20025600	usd
CY2023	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	4127088	usd
CY2022	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	20918110	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-144227	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	863719	usd
CY2023	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	30912118	usd
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	30052076	usd
CY2023	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	27708103	usd
CY2022	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	32900000	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	660000	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	962239	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	760000	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1232239	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1500000	usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1500035	usd
CY2023	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	5540543	usd
CY2022	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	940300	usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	4433552	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	231355	usd
CY2023	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	4328894	usd
CY2022	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1086860	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	8749216	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3495874	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1391813	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-1362562	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3461344	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3856167	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2952023	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6808190	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6413367	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2952023	usd
CY2023	us-gaap	Income Taxes Paid IncomeTaxesPaid	190438	usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid	151055	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	567915	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	356624	usd
CY2023	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	241678	usd
CY2022	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	732993	usd
CY2023Q2	us-gaap	Cash Cash	1109834	usd
CY2022Q2	us-gaap	Cash Cash	1134416	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	5303533	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1817607	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6413367	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2952023	usd
CY2022Q2	us-gaap	Cash Cash	1134416	usd
CY2021Q2	us-gaap	Cash Cash	3196683	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1817607	usd
CY2021Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	3611507	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2952023	usd
CY2021Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6808190	usd
CY2022	iczoom	Percentage Of Total Revenue PercentageOfTotalRevenue	0.0003	pure
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-216150	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2847	usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-1421	usd
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	216478	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3940	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	515	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3425	usd
CY2020Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6316	usd
CY2021Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2891	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Uses of estimates</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In preparing the consolidated financial statements in conformity U.S. GAAP, the management makes estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on information as of the date of the consolidated financial statements. Significant estimates required to be made by management include, but are not limited to, the valuation of accounts receivable and advance to suppliers, inventory valuations, useful lives of property and equipment and intangible assets, the recoverability of long-lived assets, realization of deferred tax assets, and provision necessary for contingent liabilities. Actual results could differ from those estimates.</p>
CY2023Q2	us-gaap	Restricted Cash Equivalents RestrictedCashEquivalents	6413367	usd
CY2022Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	18000	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	99003	usd
CY2023Q2	us-gaap	Other Receivables OtherReceivables	125125	usd
CY2022Q2	us-gaap	Other Receivables OtherReceivables	213741	usd
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	1851	usd
CY2023	iczoom	Leasehold Improvement LeaseholdImprovement	Lesser of useful life and lease term
CY2023	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y
CY2022Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	629748	usd
CY2022Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	76119299	usd
CY2023	us-gaap	Foreign Currency Transactions Description ForeignCurrencyTransactionsDescription	US$1=RMB 7.2254
CY2022	us-gaap	Foreign Currency Transactions Description ForeignCurrencyTransactionsDescription	US$1=RMB 6.7114
CY2023	us-gaap	Foreign Currency Translation Adjustment Description ForeignCurrencyTranslationAdjustmentDescription	US$1=RMB 6.9881
CY2022	us-gaap	Foreign Currency Translation Adjustment Description ForeignCurrencyTranslationAdjustmentDescription	US$1=RMB 6.4641
CY2023Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1671353	usd
CY2022Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3651700	usd
CY2023	us-gaap	Sales Type Lease Interest Income SalesTypeLeaseInterestIncome	211123155	usd
CY2022	us-gaap	Sales Type Lease Interest Income SalesTypeLeaseInterestIncome	286539736	usd
CY2023	us-gaap	Direct Financing Lease Revenue DirectFinancingLeaseRevenue	3282071	usd
CY2022	us-gaap	Direct Financing Lease Revenue DirectFinancingLeaseRevenue	3836635	usd
CY2023	us-gaap	Revenues Revenues	214405226	usd
CY2022	us-gaap	Revenues Revenues	290376371	usd
CY2022Q2	iczoom	Accounts Receivable Subsequent Collection AccountsReceivableSubsequentCollection	76119299	usd
CY2022Q2	iczoom	Accounts Receivable Rate Of Collection AccountsReceivableRateOfCollection	1	pure
CY2022	us-gaap	Depreciation Depreciation	29887	usd
CY2022Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0464	pure
CY2023Q2	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	63698	usd
CY2022Q2	us-gaap	Capitalized Software Development Costs For Software Sold To Customers CapitalizedSoftwareDevelopmentCostsForSoftwareSoldToCustomers	16351	usd
CY2023	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	437261	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	530144	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions Medicare Prescription Drug Benefit EffectiveIncomeTaxRateReconciliationDeductionsMedicarePrescriptionDrugBenefit	0.50	pure
CY2023	us-gaap	Results Of Operations Income Before Income Taxes ResultsOfOperationsIncomeBeforeIncomeTaxes	877850	usd
CY2022	us-gaap	Results Of Operations Income Before Income Taxes ResultsOfOperationsIncomeBeforeIncomeTaxes	1109748	usd
CY2023	iczoom	Value Added Tax Rate Description ValueAddedTaxRateDescription	The Company is a general taxpayer and is subject to applicable VAT tax rate of 6% or 16%, and starting from April 1, 2019, the Company is subject to applicable VAT tax rate of 6% or 13%.
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1751170	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2569810	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9201374	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8826374	shares
CY2023	iczoom	Outstanding Options OutstandingOptions	742762	shares
CY2022	iczoom	Outstanding Options OutstandingOptions	751012	shares
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	717557	shares
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	720972	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9918931	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	9547346	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.19
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.29
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.18
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.27
CY2023	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	175762	usd
CY2022	us-gaap	Other Comprehensive Income Loss Tax OtherComprehensiveIncomeLossTax	199472	usd
CY2023	iczoom	Recently Issued Accounting Pronouncements Not Yet Adopted Policy Tet Block RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyTetBlock	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i>Recently issued accounting pronouncements not yet adopted</i></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In June 2016, the FASB issued ASU 2016-13, Financial Instruments-Credit Losses (Topic 326), which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions, and reasonable and supportable forecasts. This replaces the existing incurred loss model and is applicable to the measurement of credit losses on financial assets measured at amortized cost. ASU 2016-13 was subsequently amended by Accounting Standards Update 2018-19, <i>Codification Improvements to Topic 326, Financial Instruments — Credit Losses</i>, Accounting Standards Update 2019-04 <i>Codification Improvements to Topic 326, Financial Instruments — Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments</i>, and Accounting Standards Update 2019-05, <i>Targeted Transition Relief. </i>In November 2019, the FASB issued ASU 2019-10, which extends the effective date for adoption of ASU 2016-13. In November 2019, the FASB issued ASU 2019-11 to clarify its new credit impairment guidance in ASU 326. Accordingly, for public entities that are not smaller reporting entities, ASU 2016-13 and its amendments is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. For all other entities, this guidance and its amendments will be effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. As an emerging growth company, we plan to adopt this guidance effective July 1, 2023. We are currently evaluating the impact of our pending adoption of ASU 2016-13 on our consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers (ASU 2021-08), which clarifies that an acquirer of a business should recognize and measure contract assets and contract liabilities in a business combination in accordance with Topic 606, Revenue from Contracts with Customers. The new amendments are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The amendments should be applied prospectively to business combinations occurring on or after the effective date of the amendments, with early adoption permitted. The Company is currently evaluating the impact of the new guidance on our consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In March 2022, the FASB issued ASU No. 2022-02, Financial Instruments—Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures, which eliminates the troubled debt restructurings (TDRs) accounting model for creditors that have already adopted Topic 326, which is commonly referred to as the current expected credit loss (CECL) model. For entities that have adopted Topic 326, the amendments in this Update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The FASB’s decision to eliminate the TDR accounting model is in response to feedback that the allowance under CECL already incorporates credit losses from loans modified as TDRs and, consequently, the related accounting and disclosures – which preparers often find onerous to apply – no longer provide the same level of benefit to users. The Company is currently evaluating the impact of the new guidance on our consolidated financial statements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In June 2022, the FASB issued ASU No. 2022-03, Fair Value Measurement (Topic 820) – Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions, which stipulates that a contractual restriction on the sale of an equity security should not be considered part of the equity security’s unit of account and, therefore, should not be considered in measuring its fair value. For public business entities, the amendments in this Update are effective for fiscal years beginning after December 15, 2023, and interim periods within those fiscal years. The Company is currently evaluating the impact of the new guidance on our consolidated financial statements.</p>
CY2023Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	76690246	usd
CY2022Q2	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	76119299	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	99003	usd
CY2023Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	76690246	usd
CY2022Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	76020296	usd
CY2023Q2	iczoom	Percentage Of Account Receivables PercentageOfAccountReceivables	0.631	pure
CY2023Q2	us-gaap	Accounts Receivable Net AccountsReceivableNet	76690246	usd
CY2023Q2	iczoom	Accounts Receivable Subsequent Collection AccountsReceivableSubsequentCollection	48357633	usd
CY2023Q2	iczoom	Accounts Receivable Rate Of Collection AccountsReceivableRateOfCollection	0.631	pure
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	99003	usd
CY2021Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	133059	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	99003	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	30187	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-3869	usd
CY2022Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	99003	usd
CY2023Q2	iczoom	Semiconductors Amount SemiconductorsAmount	764592	usd
CY2022Q2	iczoom	Semiconductors Amount SemiconductorsAmount	324410	usd
CY2023Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	71117	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	41205	usd
CY2023Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	1851	usd
CY2023Q2	us-gaap	Inventory Net InventoryNet	833858	usd
CY2022Q2	us-gaap	Inventory Net InventoryNet	365615	usd
CY2023Q2	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	151007	usd
CY2022Q2	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	140695	usd
CY2023Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	69782	usd
CY2022Q2	us-gaap	Construction In Progress Gross ConstructionInProgressGross	62580	usd
CY2023Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	403778	usd
CY2022Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	369065	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	624567	usd
CY2022Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	572340	usd
CY2023Q2	us-gaap	Supplies Supplies	1608941	usd
CY2022Q2	us-gaap	Supplies Supplies	6613280	usd
CY2023	iczoom	Advance To Suppliers Percentage AdvanceToSuppliersPercentage	0.862	pure
CY2023	us-gaap	Payments To Suppliers PaymentsToSuppliers	1400000	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	1490	usd
CY2021Q2	us-gaap	Short Term Investments ShortTermInvestments	928800	usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	4125704	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	20025600	usd
CY2023	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	4127088	usd
CY2022	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	20918110	usd
CY2023	us-gaap	Asset Retirement Obligation Foreign Currency Translation Gain Loss AssetRetirementObligationForeignCurrencyTranslationGainLoss	106	usd
CY2022	us-gaap	Asset Retirement Obligation Foreign Currency Translation Gain Loss AssetRetirementObligationForeignCurrencyTranslationGainLoss	34800	usd
CY2022Q2	us-gaap	Short Term Investments ShortTermInvestments	1490	usd
CY2023	us-gaap	Gain Loss On Investments GainLossOnInvestments	14748	usd
CY2022	us-gaap	Gain Loss On Investments GainLossOnInvestments	30775	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	498535	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	453096	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	126032	usd
CY2022Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	119244	usd
CY2023	us-gaap	Depreciation Depreciation	65471	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
CY2023Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1286920	usd
CY2022Q2	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	1706767	usd
CY2022Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	629748	usd
CY2023Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	54281	usd
CY2022Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	96398	usd
CY2023Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1341201	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2432913	usd
CY2023Q2	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	892703	usd
CY2023Q2	us-gaap	Advances To Affiliate AdvancesToAffiliate	21910	usd
CY2023Q2	us-gaap	Security Deposit SecurityDeposit	317459	usd
CY2023	iczoom	Other Receivable Settled Percentage OtherReceivableSettledPercentage	0.749	pure
CY2022	iczoom	Other Receivable Settled Percentage OtherReceivableSettledPercentage	0.749	pure
CY2022Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts	629748	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	905431	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	905375	usd
CY2023Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	616995	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	527037	usd
CY2023Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	288436	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	378338	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	131762	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	118184	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	88821	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	78094	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	76316	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	30840	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	11241	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	3124	usd
CY2022Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	288436	usd
CY2023Q2	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P1Y10M24D
CY2023Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0335	pure
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	432422	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	582631	usd
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	381795	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	41968	usd
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	28685	usd
CY2022Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.042	pure
CY2022Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	13900000	cny
CY2022Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	2000000	usd
CY2022Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-03-20
CY2023Q2	iczoom	Operating Lease Rightofuse Assets Gross OperatingLeaseRightofuseAssetsGross	1274479	usd
CY2022Q2	iczoom	Operating Lease Rightofuse Assets Gross OperatingLeaseRightofuseAssetsGross	732993	usd
CY2023Q2	iczoom	Operating Lease Rightofuse Assets Accumulated Amortization OperatingLeaseRightofuseAssetsAccumulatedAmortization	411627	usd
CY2022Q2	iczoom	Operating Lease Rightofuse Assets Accumulated Amortization OperatingLeaseRightofuseAssetsAccumulatedAmortization	40422	usd
CY2023Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	862852	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	692571	usd
CY2023Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	524698	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	232221	usd
CY2023Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	375056	usd
CY2022Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	480436	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	899754	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	712657	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	549919	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	376604	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	926523	usd
CY2023Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	26769	usd
CY2023Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	899754	usd
CY2023Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	11593	usd
CY2022Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	48013	usd
CY2023Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	14022523	usd
CY2022Q2	us-gaap	Short Term Borrowings ShortTermBorrowings	11760387	usd
CY2022Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	2700000	usd
CY2022Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-09-13
CY2022Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.042	pure
CY2022Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	2300000	usd
CY2022Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-09-20
CY2022Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	16100000	cny
CY2022Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	2300000	usd
CY2022Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-03-22
CY2022Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0464	pure
CY2023Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	13900000	cny
CY2023Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	2000000	usd
CY2023Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-09-17
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0464	pure
CY2023Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	16100000	cny
CY2023Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	2200000	usd
CY2023Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-09-26
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0464	pure
CY2023Q2	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	13900000	cny
CY2023Q2	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1900000	usd
CY2023Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-10-20
CY2023Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0285	pure
CY2023Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	3200000	usd
CY2023Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-08-22
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.019	pure
CY2022Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	3000000	usd
CY2022Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-02-19
CY2022Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.04	pure
CY2023Q1	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	2750000	usd
CY2023Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-08-18
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0569	pure
CY2022Q2	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1300000	usd
CY2022Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-08-12
CY2022Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.021	pure
CY2022Q2	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1300000	usd
CY2022Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-09-05
CY2022Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0215	pure
CY2022Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1300000	usd
CY2022Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-11-09
CY2022Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.031	pure
CY2022Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1200000	usd
CY2022Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-12-07
CY2022Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0319	pure
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1000000	usd
CY2022Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-02-08
CY2022Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.052	pure
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1200000	usd
CY2022Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-03-08
CY2022Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0481	pure
CY2023Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1300000	usd
CY2023Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-05-09
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0511	pure
CY2023Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1200000	usd
CY2023Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-06-07
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0495	pure
CY2023Q2	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1300000	usd
CY2023Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-08-08
CY2023Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0556	pure
CY2023Q2	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1100000	usd
CY2023Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-09-05
CY2023Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0552	pure
CY2023Q2	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	820000	gbp
CY2023Q2	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1000000	usd
CY2023Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-06-21
CY2023Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0191	pure
CY2023Q2	iczoom	Pledged Deposits PledgedDeposits	136300000	jpy
CY2023Q2	iczoom	Pledged Deposits PledgedDeposits	1000000	usd
CY2022Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	920000	gbp
CY2022Q3	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1200000	usd
CY2022Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-09-27
CY2022Q3	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0451	pure
CY2022Q3	iczoom	Pledged Deposits PledgedDeposits	144700000	jpy
CY2022Q3	iczoom	Pledged Deposits PledgedDeposits	1060000.00	usd
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	970000	eur
CY2022Q4	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1000000	usd
CY2022Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2023-11-21
CY2022Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0258	pure
CY2022Q4	iczoom	Pledged Deposits PledgedDeposits	840000	gbp
CY2022Q4	iczoom	Pledged Deposits PledgedDeposits	1030000.00	usd
CY2023Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	800000	hkd
CY2023Q1	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1500000	usd
CY2023Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-03-27
CY2023Q1	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0302	pure
CY2023Q1	iczoom	Pledged Deposits PledgedDeposits	196800000	jpy
CY2023Q1	iczoom	Pledged Deposits PledgedDeposits	1480000	usd
CY2023Q2	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	800000	gbp
CY2023Q2	us-gaap	Other Short Term Borrowings OtherShortTermBorrowings	1000000	usd
CY2023Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-06-27
CY2023Q2	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0602	pure
CY2023Q2	iczoom	Pledged Deposits PledgedDeposits	144000000	jpy
CY2023Q2	iczoom	Pledged Deposits PledgedDeposits	1000000	usd
CY2023Q2	iczoom	Related Parties Incurred Loan Origination Fee To Be Paid RelatedPartiesIncurredLoanOriginationFeeToBePaid	292998	usd
CY2022Q2	iczoom	Related Parties Incurred Loan Origination Fee To Be Paid RelatedPartiesIncurredLoanOriginationFeeToBePaid	142430	usd
CY2023	us-gaap	Deferred Finance Costs Own Share Lending Arrangement Issuance Costs Amortization Expense1 DeferredFinanceCostsOwnShareLendingArrangementIssuanceCostsAmortizationExpense1	215370	usd
CY2022	us-gaap	Deferred Finance Costs Own Share Lending Arrangement Issuance Costs Amortization Expense1 DeferredFinanceCostsOwnShareLendingArrangementIssuanceCostsAmortizationExpense1	197366	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	530568	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	293102	usd
	us-gaap	Short Term Debt Description ShortTermDebtDescription	November 2022 to March 2023
CY2022Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.036	pure
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	0	usd
CY2022Q2	iczoom	Accounts Payable Balance Percent AccountsPayableBalancePercent	0.707	pure
CY2023Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	51127328	usd
CY2023Q2	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	36149775	usd
CY2023Q2	iczoom	Accounts Payable Percentage AccountsPayablePercentage	0.707	pure
CY2022Q2	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	59558743	usd
CY2022Q2	us-gaap	Settlement Liabilities Current SettlementLiabilitiesCurrent	59558743	usd
CY2022Q2	iczoom	Accounts Payable Percentage AccountsPayablePercentage	1	pure
CY2023	us-gaap	Profit Loss ProfitLoss	2000000	hkd
CY2023	us-gaap	Profit Loss ProfitLoss	2000000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	242204	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	581282	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	23465	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	5994	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	265670	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	587276	usd
CY2023Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	406760	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	576432	usd
CY2021Q4	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	158621	usd
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	504210	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	709419	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-110932	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	-146790	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	14649	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	13543	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	3375	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	4067	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-145632	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	7037	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	265670	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	587276	usd
CY2023Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	406760	usd
CY2022Q2	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	576432	usd
CY2022Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	24751	usd
CY2023Q2	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	305	usd
CY2023Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	406760	usd
CY2022Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	576432	usd
CY2023Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	305	usd
CY2022Q2	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	24751	usd
CY2022Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	576432	usd
CY2021Q2	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	726607	usd
CY2023	iczoom	Deferred Tax Asset Value Allowance Current Period Additionreversal DeferredTaxAssetValueAllowanceCurrentPeriodAdditionreversal	-169672	usd
CY2022	iczoom	Deferred Tax Asset Value Allowance Current Period Additionreversal DeferredTaxAssetValueAllowanceCurrentPeriodAdditionreversal	8446	usd
CY2022	iczoom	Deferred Tax Effect Due To The Termination Of Vie DeferredTaxEffectDueToTheTerminationOfVIE	-158621	usd
CY2023Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2363980	usd
CY2022Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2445687	usd
CY2023Q2	iczoom	Value Added Tax Payable ValueAddedTaxPayable	-568157	usd
CY2022Q2	iczoom	Value Added Tax Payable ValueAddedTaxPayable	-229315	usd
CY2023Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	2932137	usd
CY2022Q2	us-gaap	Taxes Payable Current And Noncurrent TaxesPayableCurrentAndNoncurrent	2675002	usd
CY2023Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1508766	usd
CY2022Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	349684	usd
CY2023	us-gaap	Loan Processing Fee LoanProcessingFee	292998	usd
CY2022	us-gaap	Loan Processing Fee LoanProcessingFee	142430	usd
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	100000	cny
CY2022Q2	us-gaap	Related Party Transaction Amounts Of Transaction RelatedPartyTransactionAmountsOfTransaction	48885	usd
CY2023	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	100000000	shares
CY2023Q2	us-gaap	Sale Of Stock Price Per Share SaleOfStockPricePerShare	0.02
CY2020Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On November 13, 2020, the Company amended its Memorandum of Association to reverse split the authorized number of shares at a ratio of 1-for-4 share to 25 million shares with par value of US$0.08 per share, and reverse split the issued shares from 70,610,963 shares at par value of US$0.02 per share to 17,652,743 ordinary shares with par value of $0.08 per share. The reverse split is considered part of the Reorganization of the Company, which was retroactively applied as if the transaction occurred at the beginning of the period presented.
CY2022Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On August 8, 2022, the Company amended its Memorandum of Association to reverse split the authorized number of shares at a ratio of 1-for-2 share to 35 million shares with par value of US$0.16 per share, and reverse split the issued shares from 17,652,743 shares at par value of US$0.08 per share to 8,826,374 ordinary shares with par value of $0.16 per share. The reverse split is considered part of the Reorganization of the Company, which was retroactively applied as if the transaction occurred at the beginning of the period presented (see Note1).
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8826374	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8826374	shares
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10326374	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10326374	shares
CY2023Q2	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	21071864	usd
CY2022Q2	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	16535529	usd
CY2015Q4	us-gaap	Employee Stock Ownership Plan Esop Number Of Committed To Be Released Shares EmployeeStockOwnershipPlanESOPNumberOfCommittedToBeReleasedShares	50000000	shares
CY2015Q4	us-gaap	Share Based Goods And Nonemployee Services Transaction Shares Approved For Issuance ShareBasedGoodsAndNonemployeeServicesTransactionSharesApprovedForIssuance	6250000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	960174	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.18
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y9M18D
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	2551737	usd
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	949093	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.16
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y9M3D
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	2470526	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	209162	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.16
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	1672892
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	751012	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.16
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y18D
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	878845	usd
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	749440	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.17
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y14D
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	869478	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	8250	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.16
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	49159
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	742762	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.18
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P0Y18D
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	829686	usd
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	742762	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.18
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P0Y18D
CY2023Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	829686	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	9366	usd
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	71845	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	102783	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	54717	usd
CY2023	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P0Y
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Options Forfeited Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedNumberOfShares	209143	shares
CY2022	us-gaap	Employee Benefits And Share Based Compensation EmployeeBenefitsAndShareBasedCompensation	531616	usd
CY2022Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions	102783	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y29D
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	432422	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	582631	usd
CY2023Q2	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	144803	usd
CY2023Q2	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	93757	usd
CY2023Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	238560	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent		usd
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss		usd
CY2023Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable		usd
CY2022Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves		usd
CY2023Q2	us-gaap	Short Term Investments ShortTermInvestments		usd
CY2023Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2023Q2	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2023Q2	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts		usd
CY2023	iczoom	Deferred Tax Effect Due To The Termination Of Vie DeferredTaxEffectDueToTheTerminationOfVIE		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023Q3	us-gaap	Short Term Borrowings ShortTermBorrowings	2	usd
CY2023Q4	us-gaap	Loans Held For Sale Maturity Date LoansHeldForSaleMaturityDate	2024-04-19
CY2023Q4	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	14500000	usd
CY2023Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent		usd
CY2023Q2	us-gaap	Short Term Non Bank Loans And Notes Payable ShortTermNonBankLoansAndNotesPayable		usd
CY2023Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding		usd
CY2022Q2	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding		usd
CY2023	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown		usd
CY2023	us-gaap	Gain Loss On Contract Termination GainLossOnContractTermination		usd
CY2022	us-gaap	Increase Decrease In Notes Receivables IncreaseDecreaseInNotesReceivables		usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2023	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2023	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts		usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable		usd
CY2021	us-gaap	Increase Decrease In Customer Advances IncreaseDecreaseInCustomerAdvances		usd
CY2023Q2	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent		usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Grant Date Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2023Q2	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001854572

Files In Submission

Name	View Source	Status
0001213900-23-081728-index-headers.html	Edgar Link	pending
0001213900-23-081728-index.html	Edgar Link	pending
0001213900-23-081728.txt	Edgar Link	pending
0001213900-23-081728-xbrl.zip	Edgar Link	pending
f20f2023ex11-2_iczoom.htm	Edgar Link	pending
f20f2023ex12-1_iczoom.htm	Edgar Link	pending
f20f2023ex12-2_iczoom.htm	Edgar Link	pending
f20f2023ex13-1_iczoom.htm	Edgar Link	pending
f20f2023ex2-3_iczoom.htm	Edgar Link	pending
f20f2023ex8-1_iczoom.htm	Edgar Link	pending
f20f2023_iczoom.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
iczoom-20230630.xsd	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
image_005.jpg	Edgar Link	pending
image_006.jpg	Edgar Link	pending
image_007.jpg	Edgar Link	pending
image_008.jpg	Edgar Link	pending
image_009.jpg	Edgar Link	pending
image_010.jpg	Edgar Link	pending
image_011.jpg	Edgar Link	pending
image_012.jpg	Edgar Link	pending
image_013.jpg	Edgar Link	pending
image_014.jpg	Edgar Link	pending
image_015.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
iczoom-20230630_def.xml	Edgar Link	unprocessable
iczoom-20230630_lab.xml	Edgar Link	unprocessable
iczoom-20230630_pre.xml	Edgar Link	unprocessable
f20f2023_iczoom_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
iczoom-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IZM
ICZOOM Group Inc. Stock $izm

2023 Q3 Form 20-F Financial Statement

#000121390023081728 Filed on October 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IZM ICZOOM Group Inc. Stock $izm

2023 Q3 Form 20-F Financial Statement

#000121390023081728 Filed on October 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IZM
ICZOOM Group Inc. Stock $izm